Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies
Authors:
- Trudy N. SmallTSTrudy N. Small
- James W. YoungJYJames W. Young
- Hugo Castro-MalaspinaHCHugo Castro-Malaspina
- Susan ProckopSPSusan Prockop
- Andrew WiltonAWAndrew Wilton
- Glenn HellerGHGlenn Heller
- Farid BouladFBFarid Boulad
- Michelle ChiuMCMichelle Chiu
- Katherine HsuKHKatherine Hsu
- Ann JakubowskiAJAnn Jakubowski
- Nancy A. KernanNKNancy A. Kernan
- Miguel-Angel PeralesMPMiguel-Angel Perales
Open Access
- 1 February 2007
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (2) , 235-244
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Graft-Versus-Host Disease and Graft-Versus-Leukemia After Donor Leukocyte InfusionSeminars in Hematology, 2006
- Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysisLeukemia, 2005
- Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancerBlood, 2005
- Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of ageBlood, 2005
- High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaBone Marrow Transplantation, 2005
- Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDSBlood, 2004
- Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantationBlood, 2003
- Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemiaAmerican Journal of Hematology, 2001
- Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)Bone Marrow Transplantation, 2000
- Allogeneic Bone Marrow Transplantation after Hyperfractionated Total-Body Irradiation and Cyclophosphamide in Children with Acute LeukemiaNew England Journal of Medicine, 1987